<SEC-DOCUMENT>0001628280-22-026685-index.html : 20221019
<SEC-HEADER>0001628280-22-026685.hdr.sgml : 20221019
<ACCEPTANCE-DATETIME>20221019200717
ACCESSION NUMBER:		0001628280-22-026685
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20221019
FILED AS OF DATE:		20221019
DATE AS OF CHANGE:		20221019

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			LEE ANN L.
		CENTRAL INDEX KEY:			0001723629

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41536
		FILM NUMBER:		221319563

	MAIL ADDRESS:	
		STREET 1:		400 DEXTER AVENUE NORTH
		STREET 2:		SUITE 1200
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98109

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Prime Medicine, Inc.
		CENTRAL INDEX KEY:			0001894562
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		21 ERIE ST.
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		617-465-0013

	MAIL ADDRESS:	
		STREET 1:		21 ERIE ST.
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>wf-form3_166622440924006.xml
<DESCRIPTION>FORM 3
<TEXT>
Document 1 - file: wf-form3_166622440924006.html

Document 1 - RAW XML: wf-form3_166622440924006.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ex-24.htm
<DESCRIPTION>ANN L. LEE - POA
<TEXT>
Document 2 - file: ex-24.htm

</DOCUMENT>
</SEC-DOCUMENT>